News

Can Ozempic and other GLP-1 drugs be substitute for work outs? Dr Ambrish Mithal and Raj Ganpath discuss
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
News-Medical.Net on MSN2h
Retrospective analyses indicate Ozempic’s protective effects against stroke fatality
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
Dr Ambrish Mithal decodes Ozempic and other GLP-1 drugs, with Raj Ganpath
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
Weight loss drugs like Ozempic may help prevent stroke and reduce brain injury-related complications, studies show
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
Onlymyhealth on MSN35m
Don't Just Take Medication, Take Control: US Hospitals Recommend The MEAL Plan For Weight Loss Success
As medications like 'Wegovy' and 'Ozempic' (GLP‑1 receptor agonists) become more common in weight‑loss strategies, US ...
As a reporter, I've covered all things GLP-1. Here's what I've learned.
After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...
I lost over 3 stone on Mounjaro but here’s 5 things I wish I knew before – the fashion identity crisis is just the start
A MOTHER has managed to shift over three stone thanks to Mounjaro, but has revealed the five things she wishes she had known ...
I lost 8st in a YEAR on Mounjaro – I had to have an organ removed but I still went back on the jabs as soon as I could
A WOMAN has revealed how shedding a whopping 8st completely transformed her life but also landed her in a major surgery. The weight loss warrior, Em, has been documenting her transformation on her ...
B.C. limits sale of 2 more diabetes drugs used for weight loss
British Columbia's Ministry of Health is limiting the sales of two more diabetes drugs to curb their off-label use for weight ...